Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -6,770 | N/A |
| Depreciation Amortization | N/A | N/A | 40 | 30 | N/A |
| Other Working Capital | N/A | N/A | 70 | 1,540 | N/A |
| Other Operating Activity | 0 | 0 | 3,500 | 2,870 | 0 |
| Operating Cash Flow | $N/A | $N/A | $3,610 | $-2,330 | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | -50 | -210 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-50 | $-210 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 560 | 2,710 | 0 |
| Financing Cash Flow | $N/A | $N/A | $560 | $2,710 | $N/A |
| Beginning Cash Position | N/A | N/A | N/A | 800 | N/A |
| End Cash Position | N/A | N/A | N/A | 970 | N/A |
| Net Cash Flow | $N/A | $N/A | $4,120 | $160 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | 3,610 | -2,330 | N/A |
| Free Cash Flow | 0 | 0 | 3,610 | -2,330 | 0 |